Dr. Slavin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
City of Hope
1500 E. Duarte Rd, Duarte, CA 91010
Duarte, CA 91010Phone+1 626-256-8662- Is this information wrong?
Summary
- Dr. Thomas Slavin is a medical geneticist in Duarte, CA and is affiliated with City of Hope's Helford Clinical Research Hospital. He received his medical degree from University of South Florida College of Medicine and has been in practice 12 years. He specializes in clinical cancer genetics.
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Pediatrics/Medical Genetics and Genomics, 2005 - 2010
- Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 2005 - 2008
- University of South Florida College of MedicineClass of 2005
- University of South FloridaB.S., Biology, Cum Laude, 1997 - 2001
Certifications & Licensure
- CA State Medical License 2014 - 2024
- HI State Medical License 2010 - 2016
- OH State Medical License 2005 - 2012
- American Board of Pediatrics Pediatrics
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
- American Board of Clinical ChemistryBoard certification in Molecular Diagnostics
Awards, Honors, & Recognition
- Research Career Development Award Recipient STOP CANCER, 2015
- Fellow American College of Medical Genetics and Genomics, 2012
- Pediatric Residency International Health Track Distinction (Roatan, Honduras) 2008
- Join now to see all
Publications & Presentations
PubMed
- 96 citationsCirculating tumor DNA as an early cancer detection tool.Andrea Campos-Carrillo, Jeffrey N. Weitzel, Prativa Sahoo, Russell C. Rockne, Janet V. Mokhnatkin, Muhammed Murtaza, Stacy W. Gray, Laura H. Goetz, Ajay Goel, Nicholas...> ;Pharmacology & Therapeutics. 2020 Mar 1
- 2 citationsExperience Gained from the Development and Execution of a Multidisciplinary Multi-syndrome Hereditary Colon Cancer Family ConferenceIlana Solomon, Christina Rybak, Lily R. Van Tongeren, Lili Kuzmich, Kathleen R. Blazer, Bita Nehoray, Mariana Niell-Swiller, Shawnie Bray, Travis Bray, Karen Hurley, J...> ;Journal of Cancer Education. 2019 Dec 1
- 21 citationsPrevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testing.Thomas P. Slavin, Bradford Coffee, Ryan Bernhisel, Jennifer Logan, Hannah C. Cox, Guido Marcucci, Jeffrey N. Weitzel, Susan L. Neuhausen, Debora Mancini-DiNardo> ;Cancer Genetics. 2019 Apr 13
- Join now to see all
Journal Articles
- Specifications of the ACMG/AMP Variant Curation Guidelines for the Analysis of Germline CDH1 Sequence VariantsSharon E Plon, Chimene Kesserwan, Thomas P Slavin, Liying Zhang, Human Mutation
- Clinical application of multigene panels: challenges of next-generation counseling and cancer risk managementSlavin TP, Niell-Swiller M, Solomon I, Nehoray B, Rybak C, Blazer KR, Weitzel JN, Front. Oncol., 1/29/2015
- Congenital diaphragmatic hernia in a fetus with a de novo terminal deletion of chromosome 15q261Ruth C, Starcevic J, Bartholomew ML, Qin N, Slavin TP, Hereditary Genetics, 1/1/2012
Books/Book Chapters
Abstracts/Posters
- Multiplex Identification of genetic etiologies among women with bilateral breast cancer using a 25gene hereditary cancer panel.Weitzel JN, Blazer KR, Nehoray B, Kidd J, Slavin TP, Solomon I, Niell-Swiller M, Rybak C, Saam J, Lancaster J, San Antonio Breast Cancer Symposium, NM, 1/1/2015
- How big of a role does TP53 play in BRCA1/2 negative familial breast cancer? Data from the SIMPLEXO consortium.Slavin TP, Maxwell KN, Hart S, Vijai J, Schrader K, Guidugli L, Thomas T, Moore R, Hu C, Wubbenhorst B, Domchek SM, Robson ME, Radice P, Peterlongo P, Ford J, Garber J..., American Society of Human Genetics Annual Meeting, Baltimore, MD, 1/1/2015
- The contribution of high and moderate penetrance breast cancer susceptibility genes to familial breast cancer risk in BRCAx families.Maxwell KN, Hart S, Vijai J, Schrader K, Slavin TP, Thomas T, Moore R, Hu C, Wubbenhorst B, Domchek SM, Robson ME, Radice P, Peterlongo P, Ford J, Garber J, Szabo C, N..., American Society of Human Genetics Annual Meeting, 1/1/2015
- Join now to see all
Lectures
- Effect of germline ATM mutations on clonal hematopoiesis.2019 ASCO Annual Meeting - 6/1/2019
- Understanding the NGS Test report: a primer on genomics nomenclature.1/27/2015
- Updates in Li Fraumeni syndrome screening.City of Hope - 1/26/2015
- Join now to see all
Other
- "Genodermatoses in cancer"Slavin TP, Intensive Course in Cancer Genetics (Video)
City of Hope - 1/10/2014 - Visual Diagnosis: Newborn with Unilateral Lower Extremity Vascular Malformation and Limb Asymmetry.Wong Ramsey K, Slavin TP, Tjoeng T, Jain S, NeoReviews Vol. 15 No. 2
http://neoreviews.aappublications.org/content/15/2/e82.short
1/1/2014 - "Genetic Testing"Slavin TP, The Body Show with Kathy Kozak, Hawai'i Public Radio
1/10/2013
Press Mentions
- Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction Than Standard-of-Care Risk ModelDecember 9th, 2022
- What Causes Breast Cancer, Exactly? Doctors Explain What We Know—and How Testing Can HelpMay 5th, 2022
- Genomic Instability Varies Between Breast Cancer SubtypesDecember 10th, 2021
- Join now to see all
Hospital Affiliations
- City of Hope Comprehensive Cancer CenterDuarte, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: